EHC analyst estimates
Encompass Health (EHC) analyst ratings, the average price target and its range, and every firm's latest call.
EHC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | Truist Financial | Encompass Health Corp (EHC) PT Raised to $156 at Truist Securities, 'We remain bullish' | $156.00 |
| Oct 30, 2026 | KeyBanc | Encompass Health Corp (EHC) PT Raised to $150 at KeyBanc | $150.00 |
| Oct 30, 2026 | UBS | Encompass Health Corp (EHC) PT Raised to $165 at UBS | $165.00 |
| Oct 30, 2026 | Raymond James | Encompass Health Corp (EHC) PT Raised to $155 at Raymond James | $155.00 |
| Oct 29, 2026 | Barclays | Encompass Health price target raised to $151 from $144 at Barclays | $151.00 |
| Sep 28, 2026 | Raymond James | Raymond James Assumes Encompass Health Corp (EHC) at Strong Buy | $150.00 |
| Aug 7, 2026 | UBS | Encompass Health price target raised to $155 from $150 at UBS | $155.00 |
| Aug 7, 2026 | Truist Financial | Encompass Health price target raised to $150 from $140 at Truist | $150.00 |
| Aug 6, 2026 | Barclays | Encompass Health price target raised to $144 from $140 at Barclays | $144.00 |
| May 22, 2026 | Leerink Partners | Encompass Health Corp (EHC) PT Raised to $152 at Leerink | $152.00 |
| May 5, 2026 | Barclays | Encompass Health price target lowered to $140 from $153 at Barclays | $140.00 |
| Feb 6, 2026 | Barclays | Encompass Health price target raised to $153 from $150 at Barclays | $153.00 |
| Oct 30, 2025 | Barclays | Encompass Health price target raised to $150 from $141 at Barclays | $150.00 |
| Oct 2, 2025 | UBS | Encompass Health price target raised to $150 from $140 at UBS | $150.00 |
| Aug 14, 2025 | Truist Financial | Encompass Health price target raised to $140 from $135 at Truist | $140.00 |
- 5 firms rate EHC: 5 buy, 0 hold, 0 sell.
- The average price target is $154.83 from 6 analysts, from $150.00 to $165.00.
Updated 2026-11-03 00:00 UTC